AI assistant
Sending…
KEWAUNEE SCIENTIFIC CORP /DE/ — Director's Dealing 2017
Sep 8, 2017
34045_dirs_2017-09-08_f2fd3003-2881-4177-a74c-aa9252b7dd55.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
CIK: 0000055529
Period of Report: 2017-09-08
Reporting Person: Dahlgren Dana L (VP-Sales & Marketing-Americas)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-08 | Common Stock | M | 2250 | $18.14 | Acquired | 6689 | Direct |
| 2017-09-08 | Common Stock | M | 1500 | $16.97 | Acquired | 8189 | Direct |
| 2017-09-08 | Common Stock | M | 750 | $23.62 | Acquired | 8939 | Direct |
| 2017-09-08 | Common Stock | F | 3127 | $26.85 | Disposed | 5812 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-08 | Option to Buy | $18.14 | M | 2250 | Disposed | 2024-08-27 | Common Stock (2250) | Direct |
| 2017-09-08 | Option to Buy | $16.97 | M | 1500 | Disposed | 2025-08-26 | Common Stock (1500) | Direct |
| 2017-09-08 | Option to Buy | $23.62 | M | 750 | Disposed | 2026-08-31 | Common Stock (750) | Direct |
Footnotes
F1: Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon this exercise as reported below on this Form 4 report.
F2: Employee stock option granted under Employee Stock Option plan under Rule 16b-3.
More from KEWAUNEE SCIENTIFIC CORP /DE/
Regulatory Filings
2026
May 1
Director's Dealing
2026
Mar 27
Interim / Quarterly Report
2026
Mar 13
Regulatory Filings
2026
Mar 11
Report Publication Announcement
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 2
Director's Dealing
2025
Dec 31